These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 37189347)

  • 1. Antimicrobial Peptides (AMPs): Potential Therapeutic Strategy against Trypanosomiases?
    Rojas-Pirela M; Kemmerling U; Quiñones W; Michels PAM; Rojas V
    Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrasubstituted Imidazolium Salts as Potent Antiparasitic Agents against African and American Trypanosomiases.
    Ghashghaei O; Kielland N; Revés M; Taylor MC; Kelly JM; Di Pietro O; Muñoz-Torrero D; Pérez B; Lavilla R
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29337878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanocidal Essential Oils: A Review.
    Morais MC; Souza JV; da Silva Maia Bezerra Filho C; Dolabella SS; Sousa DP
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33036315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diamidine activity against trypanosomes: the state of the art.
    Soeiro MN; de Castro SL; de Souza EM; Batista DG; Silva CF; Boykin DW
    Curr Mol Pharmacol; 2008 Jun; 1(2):151-61. PubMed ID: 20021429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trypanosomiases].
    Pelloux H; Aznar C; Bouteille B
    Rev Prat; 2006 Dec; 56(20):2209-16. PubMed ID: 17352316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
    Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Flavanones as Scaffolds for the Development of New Treatments against Malaria and African and American Trypanosomiases.
    Boniface PK; Ferreira EI; Fabrice FB
    Mini Rev Med Chem; 2023; 23(14):1479-1498. PubMed ID: 36582061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanocidal drugs: mechanisms, resistance and new targets.
    Wilkinson SR; Kelly JM
    Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antitrypanosomal agents.
    Steverding D; Tyler KM
    Expert Opin Investig Drugs; 2005 Aug; 14(8):939-55. PubMed ID: 16050789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid-Compounds Against Trypanosomiases.
    Nunes JA; Ferreira da Silva-Júnior E
    Curr Drug Targets; 2022; 23(14):1319-1329. PubMed ID: 35579157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.
    Bastos IM; Motta FN; Grellier P; Santana JM
    Curr Med Chem; 2013; 20(25):3103-15. PubMed ID: 23514419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosomatid parasites causing neglected diseases.
    Nussbaum K; Honek J; Cadmus CM; Efferth T
    Curr Med Chem; 2010; 17(15):1594-617. PubMed ID: 20166934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The trypanosomiases.
    Barrett MP; Burchmore RJ; Stich A; Lazzari JO; Frasch AC; Cazzulo JJ; Krishna S
    Lancet; 2003 Nov; 362(9394):1469-80. PubMed ID: 14602444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of plant-based products in the treatment of Trypanosoma cruzi and Trypanosoma brucei infections: a systematic review of preclinical in vivo evidence.
    Pereira RM; Greco GMZ; Moreira AM; Chagas PF; Caldas IS; Gonçalves RV; Novaes RD
    Parasitology; 2017 Sep; 144(10):1275-1287. PubMed ID: 28578742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The animal trypanosomiases and their chemotherapy: a review.
    Giordani F; Morrison LJ; Rowan TG; DE Koning HP; Barrett MP
    Parasitology; 2016 Dec; 143(14):1862-1889. PubMed ID: 27719692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cruzain and Rhodesain Inhibitors: Last Decade of Advances in Seeking for New Compounds Against American and African Trypanosomiases.
    Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
    Curr Top Med Chem; 2021; 21(21):1871-1899. PubMed ID: 33797369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repositioning of leishmanicidal [1,2,3]Triazolo[1,5-a]pyridinium salts for Chagas disease treatment: Trypanosoma cruzi cell death involving mitochondrial membrane depolarisation and Fe-SOD inhibition.
    Martín-Escolano R; Martín-Escolano J; Ballesteros-Garrido R; Cirauqui N; Abarca B; Rosales MJ; Sánchez-Moreno M; Ballesteros R; Marín C
    Parasitol Res; 2020 Sep; 119(9):2943-2954. PubMed ID: 32607710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
    Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
    ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eflornithine. A new drug in the treatment of sleeping sickness.
    Van Bogaert I; Haemers A
    Pharm Weekbl Sci; 1989 Jun; 11(3):69-75. PubMed ID: 2505225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted proteases of Trypanosoma brucei gambiense: possible targets for sleeping sickness control?
    Bossard G; Cuny G; Geiger A
    Biofactors; 2013; 39(4):407-14. PubMed ID: 23553721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.